Table 2.
Contingency analysis of cytoplasmic phosphorylated RKIP (c-pRKIP), nuclear phosphorylated RKIP (n-pRKIP) and nuclear STAT3 (n-STAT3) expression and tumor Grade and LVI status
| Marker | Grade | p-value | LVI | p-value | ||
|---|---|---|---|---|---|---|
| |
Low |
High |
|
Absent |
Present |
|
| c-pRKIP |
n (%) |
n (%) |
0.024 |
n (%) |
n (%) |
0.29 |
| 0, 1+, 2+ |
46 (74%) |
16 (26%) |
|
55 (89%) |
7 (11%) |
|
| 3+ |
59 (89%) |
7 (11%) |
|
62 (94%) |
4 (6%) |
|
| n-pRKIP |
n (%) |
n (%) |
0.399 |
n (%) |
n (%) |
0.06 |
| 0 |
16 (89%) |
2 (11%) |
|
18 (100%) |
0 (0%) |
|
| 1+, 2+, 3+ |
90 (81%) |
21 (19%) |
|
100 (90%) |
11 (10%) |
|
| n-STAT3 |
n (%) |
n (%) |
0.064 |
n (%) |
n (%) |
0.038 |
| 0 |
19 (95%) |
1 (5%) |
|
20 (100%) |
0 (0%) |
|
| 1+, 2+, 3+ | 86 (80%) | 22 (20%) | 96 (89%) | 12 (11%) | ||
The numbers and the percentages of cases are provided.